Cambrex
CBM | US
Overview
Corporate Details
- ISIN(s):
- US1320111073
- LEI:
- 4Q9DLX2VIFGJMOYJ4Y35
- Country:
- United States of America
- Address:
- N/A
- Website:
- https://www.cambrex.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
Automate Your Workflow. Get a real-time feed of all Cambrex filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Cambrex
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cambrex via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops patented, tobacco-free, dissolvable nicotine strips for rapid and discreet delivery.
Sweden
NICO
Sweden
NICO
Develops generic drugs, allergy treatments, and novel pharmaceuticals for a global market.
Japan
4539
Japan
4539
Develops pharmaceuticals and functional foods to improve healthcare and wellbeing.
Japan
4516
Japan
4516
Global manufacturer of renal care devices, injectable drugs, and pharmaceutical packaging.
Japan
8086
Japan
8086
Developing off-the-shelf NK cell therapies for cancer and autoimmune diseases.
United States of America
NKTX
United States of America
NKTX
Biotech firm for NK cell therapies, global research reagents, diagnostics, and supplements.
South Korea
182400
South Korea
182400
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan
4893
Japan
4893
Develops clinically-proven anti-infective therapies for eyecare, skincare, and wound care.
United States of America
NBY
United States of America
NBY
Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.
France
ALNOV
France
ALNOV
Develops and markets innovative medicines globally using advanced science and technology.
Switzerland
NOVN
Switzerland
NOVN